Skip to main content
. Author manuscript; available in PMC: 2023 Jul 24.
Published in final edited form as: Exp Hematol. 2022 Sep 30;115:14–19. doi: 10.1016/j.exphem.2022.09.003

Figure 2. Distinct ASXL1 mutation spectrums in CHIP vs myeloid diseases.

Figure 2.

This figure summarizes published datasets of CHIP in healthy elderlies and cancer patients and of patients with myeloid diseases (including MPN, MDS, CMML, and AML).